ASTRAZEN - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 05 Nov 25, 7:43 am

Technical Rating: 4.2

Technical Analysis Report

• Trend Status: Trending upward
• Moving Averages: Price (₹9,792) is above both 50 DMA (₹9,119) and 200 DMA (₹8,482), indicating strong bullish alignment
• RSI (68.3): Bullish momentum, nearing overbought zone
• MACD (107): Strong positive crossover, confirming upward momentum
• Bollinger Bands: Price near upper band, suggesting potential short-term resistance
• Volume: Above average (21K vs 13K), showing strong market interest
• Support Zones: ₹9,600, ₹9,300
• Resistance Zones: ₹9,950, ₹10,200
• Entry Zone: ₹9,600–₹9,750 (near support)
• Exit Zone: ₹9,950–₹10,200 (near resistance)

Positive

• Price above both key moving averages confirms bullish trend
• MACD and RSI support continued upward momentum
• Strong ROCE (33.4%) and ROE (23.6%) reflect excellent operational efficiency
• Low debt-to-equity ratio (0.05) indicates financial prudence
• EPS of ₹73.3 and stable dividend yield of 0.32%

Limitation

• RSI approaching overbought zone may limit short-term upside
• High P/E (116) and PEG (2.68) suggest premium valuation

Company Negative News

• Quarterly PAT declined from ₹62.3 Cr to ₹56.1 Cr
• FII holding dropped by 0.29%, reflecting cautious foreign sentiment

Company Positive News

• Quarterly profit variation of +60.1% shows strong year-over-year growth
• DII holding increased by 0.71%, indicating domestic institutional confidence
• Stock has gained 79.9% from its 52-week low

Industry

• Pharmaceutical sector remains resilient with strong demand for specialty and chronic care drugs
• Industry P/E of 33.1 suggests ASTRAZEN trades at a significant premium

Conclusion

• ASTRAZEN is in a bullish trend with strong technical indicators and institutional support
• Entry near ₹9,600–₹9,750 offers a tactical opportunity
• Exit near ₹9,950–₹10,200 is ideal for short-term gains
• Investors should monitor RSI and valuation metrics for signs of trend exhaustion